Health Tech Bakul Patel, director of digital health at the FDA Michael J. Ermarth/FDA Q&A: The FDA’s digital health chief on how to regulate futuristic AI products Log In | Learn More Tags Artificial Intelligencegovernment agenciespolicySTAT+ SILVER SPRING, Md. — The Food and Drug Administration has allowed medical devices that rely on artificial intelligence algorithms onto the market, but so far, the agency has given the green light only to devices with “locked algorithms” — those that remain the same as the product is used until they’re updated by the manufacturer.Systems with algorithms that evolve and sharpen on their own, however, are already in development. [email protected] Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+. First 30 days free. GET STARTED What’s included? About the Author Reprints What is it? GET STARTED STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. By Andrew Joseph Aug. 9, 2019 Reprints General Assignment Reporter Andrew covers a range of topics, from addiction to public health to genetics. Andrew Joseph @DrewQJoseph Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.